title: mTOR immunosuppression in HIV-positive liver transplant recipients.
authors.forename: Umberto
authors.initials: U
authors.lastname: Baccarani
authors.forename: Gian Luigi
authors.initials: GL
authors.lastname: Adani
authors.forename: Marcello
authors.initials: M
authors.lastname: Tavio
authors.forename: Paolo
authors.initials: P
authors.lastname: Grossi
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Viale
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D006678:HIV / Q000235:genetics; D006679:HIV Seropositivity / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000276:immunology*; D012367:RNA, Viral / Q000235:genetics; D058570:TOR Serine-Threonine Kinases / Q000627:therapeutic use*
chemical_list: D044966:Anti-Retroviral Agents; D012367:RNA, Viral; D058570:TOR Serine-Threonine Kinases